Other papers submitted by: Dr Matthew J Taylor

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Matthew J Taylor

Papers published by Dr Matthew J Taylor:

Original Research

Highly-accessed

Standard Gamble to Derive Utility Health States for Limbal Stem Cell Deficiency

Smith AB, Retzler J, Taylor MJ

ClinicoEconomics and Outcomes Research 2020, 12:535-546

Published Date: 15 September 2020

Original Research

Noteworthy comment: This study assessed different methods to determine whether high ICERs (incremental cost-effectiveness ratio) are caused by high drug costs, high ‘background costs’ or a combination of both and how different approaches can alter the impact of background costs on the ICER where the marginal cost-effectiveness ratio is close to, or above, the cost-effectiveness threshold.

Highly-accessed

The impact of increased post-progression survival on the cost-effectiveness of interventions in oncology

Retzler J, Davies H, Jenks M, Kiff C, Taylor M

ClinicoEconomics and Outcomes Research 2019, 11:309-324

Published Date: 3 May 2019

Original Research

Highly-accessed

Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany

Green W, Kleine-Tebbe J, Klimek L, Hahn-Pedersen J, Nørgaard Andreasen J, Taylor M

ClinicoEconomics and Outcomes Research 2017, 9:77-84

Published Date: 16 February 2017

Original Research

Highly-accessed

Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children

Ronaldson S, Taylor M, Bech PG, Shenton R, Bufe A

ClinicoEconomics and Outcomes Research 2014, 6:187-196

Published Date: 8 April 2014